, office-based Clinical Data Coordinator to join our Data Management team in Japan. This position will work on a team... Medpace Overview Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical...
-time, office-based Regulatory Submissions Coordinator to join our Clinical Operations team in Japan. This position plays... clinical contract research organization (CRO). We provide Phase I-IV clinical development services to the biotechnology...
Job Summary We are currently seeking new grads for full-time, office-based Project Coordinator to join our Clinical... company’s success. If you want an exciting career where you can develop clinicalresearch expertise, then this is the...
: Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services... RSP (Randomization & Study Project) Coordinator to join our team in Japan. By working with the RSPM Project Manager...
Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services... (Randomization & Study Project) Coordinator to join our team in Japan. By working with the RSPM Project Manager and other team...
ResearchCoordinator within the past five years or current certification as a Certified Clinical Trial Investigator (CCTI...), Certified ClinicalResearchCoordinator (CCRC), or Certified ClinicalResearch Professional (CCRP) from the Association...
With the government announcing big spending and tax, the differences between the two main parties feel sharper, writes Laura Kuenssberg. Continue Reading »
FPIs offloaded ₹94,017 crore worth of Indian equities, and the net outflow stood at ₹96,358 crore as of October 31, taking into account debt, hybrid, debt-VRR, and equities Continue Reading »
Dividend Stocks: Several companies, including HCL Technologies, L&T Technology, Dalmia Bharat, among others are trading ex-dividend in the coming week. Continue Reading »
Berkshire Hathaway's stake in Apple was valued at $69.9 billion at the end of the quarter, down from $84.2 billion in the second quarter, indicating that the conglomerate cut its stake by about 25 per cent Continue Reading »
While inviting suggestions of public, Sebi has released a consultation paper on the review of issue and listing of securitised debt instruments. These relate to the ticket size, offer period, definition of debt, rights of investors, among other criteria Continue Reading »
With Q2 results due on November 8, analysts forecast a strong performance for State Bank of India, projecting a 14.5% net profit increase. The stock target is set at ₹874, supported by solid credit growth expectations. Continue Reading »
Brent futures were up 29 cents, or 0.4 per cent, to settle at $73.10 a barrel. US West Texas Intermediate (WTI) crude gained 23 cents, or 0.3 per cent, to settle at $69.49 Continue Reading »
IPO News Today highlights on November 2, 2024: Explore the latest on initial public offerings (IPOs), featuring insights into newly public companies and market trends. Get the details on upcoming IPOs, pricing strategies, and how these new stocks perform on the exchange, providing crucial information for investors and market watchers Continue Reading »
Swiggy IPO will launch on November 6, aiming to raise ₹11,327 crore. The price band is set at ₹371- ₹390 per share, with a minimum investment of ₹14,820. Prominent investors have bid over $15 billion, significantly exceeding the reserved portion. Continue Reading »